PortfolioPortfolio mode

MRK

Merckstock

$145.191.48% today

Trade MRK

← Research only mode

Research MRK

MRK · 90-day price history

Market cap

$358.9B

P/E

115.4

Div yield

2.34%

Industry

Drug Manufacturers - General

Exchange

NYSE

Website ↗

Prediction models

All predictions →

Trend follower

Horizon: 1 week

down

Signal strength0.13

Historical accuracy51%

92 predictions · 12mBaseline 47%

How this works

Compares a 10-day vs 50-day moving average. When the short-term average rises above the long-term average, the trend is up.

Not financial advice. Past accuracy does not guarantee future results.

Momentum

Horizon: 1 week

Signal strength0.23

Historical accuracy25%

92 predictions · 12mBaseline 47%

How this works

Uses RSI (a gauge of recent buying/selling intensity) and 5-day rate-of-change to judge whether the stock has been pushed too far in one direction.

Not financial advice. Past accuracy does not guarantee future results.

Statistical trend

Horizon: 1 month

Signal strength0.51

Historical accuracy47%

75 predictions · 12mBaseline 67%

How this works

Fits a trend line through the last 60 days of prices and measures how far the current price has strayed from it.

Not financial advice. Past accuracy does not guarantee future results.

Multi-factor + news

Horizon: 1 week

AI + NEWS

flat

Signal strength0.01

Historical accuracy50%

30 predictions · 12mBaseline 47%

Accuracy reflects technical signals only. News sentiment is live.

How this works

Combines trend (25%), momentum (25%), volume (15%), and AI-analysed news sentiment (35%) from your trusted sources into one score.

Not financial advice. Past accuracy does not guarantee future results.

Bull / Bear thesis

AI analysis

Bull case●

Oncology pipeline expansion with near-term catalysts

Will unveil first-time pivotal Phase 3 data at ESMO 2026 for melanoma and endometrial cancer

Yahoo

Benefiting from healthcare sector rotation

Healthcare gaining as investors rotate away from AI concerns

Price action

Premium valuation justified by pipeline

Trading at 5.5x sales reflects market belief in strong oncology pipeline execution

Yahoo

Bear case●

Down 1.48% despite sector strength

Healthcare rotating in but MRK underperforming UNH, ABBV, LLY

Price action

Premium valuation carries execution risk

At 5.5x sales vs 3.1x for S&P 500; new pipeline data must significantly exceed expectations

Yahoo

Competing in crowded oncology space

While MRK waits for 2026 data, AbbVie and Eli Lilly showing earlier wins

Price action

AI-generated from recent news and price action. Not financial advice. Educational only.

Seasonality

~5y of history

Avg return by month · %

This month historically: +1.17% on average, up 40% of 5 years.

Avg return by weekday · %

Historical pattern only — seasonality is not a prediction and often breaks.

Recent news

How Has Merck's Story Changed?

Yahoo · Oct 15

Explains MRK's shift to oncology focus and why premium valuation is strategic bet.

What Could Merck (MRK) Reveal At ESMO 2026 About Its Oncology Pipeline?

Yahoo · Oct 15

ESMO 2026 conference will be key catalyst for MRK to validate oncology pipeline thesis.

AI research companion

AI Research Companion

Loading…